Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase IIb/III study of oral masitinib in PPMS and nSPMS meets primary endpoint

Feb. 21, 2020

EncuraGen presents new ADIPOR1 agonist BHD-1028 for type 2 diabetes, obesity and NASH

Feb. 21, 2020

Chloroquine phosphate improves COVID-19-associated pneumonia in patients

Feb. 21, 2020

Oncofid-P-b shows promise in bladder cancer patients unresponsive to BCG

Feb. 21, 2020

Antabio SAS discovers serine beta-lactamase inhibitors

Feb. 21, 2020

Artios Pharma patents DNA polymerase eta inhibitors

Feb. 21, 2020

Sumitomo Dainippon Pharma describes anticancer chromen derivatives

Feb. 21, 2020

Bristol-Myers Squibb discovers toll-like receptor 7 agonists

Feb. 21, 2020

New CDK8/19 inhibitors described by Biocad CJSC

Feb. 21, 2020

AT-845 shows safety and robust efficacy in preclinical models

Feb. 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...